Additionally, studies have indicated a down-regulation of TET1 in early-stage colon tumors, where the decreased expression of TET1 during the initiation of colon cancer suppresses the promoters of WNT pathway inhibitors, leading to a persistent activation of the WNT pathway [4]. The gene discussed is TET1; the disease is malignant colon neoplasm.